Neuroblastoma: all 634 studies
Page 6 of 7. Open to participants first (122), then studies with results posted, then the rest; newest registration first within each.
- Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 NeuroblastomaStatus unknownNCT00416676Phase 3
- Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery OnlyStatus unknownNCT00416559Phase 2
- Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantCompletedNCT00410657Phase 2
- Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With NeuroblastomaStatus unknownNCT00410631Phase 3
- Clinical Studies of Gemcitabine-OxaliplatinCompletedNCT00407433Phase 2
- A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell TransplantationCompletedNCT00405327Phase 2
- Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 NeuroblastomaStatus unknownNCT00392340Phase 2
- High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk NeuroblastomaWithdrawnNCT00389766Phase 2
- Combination Chemotherapy in Treating Young Patients Who Are Undergoing Surgery and an Autologous Bone Marrow Transplant for Disseminated NeuroblastomaCompletedNCT00365755Phase 3
- Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With CancerStatus unknownNCT00349024Not applicable
- Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell TransplantationCompletedNCT00336531Phase 4
- Ixabepilone in Treating Young Patients With Refractory Solid TumorsCompletedNCT00331643Phase 2
- Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantTerminatedNCT00324324Phase 3
- Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid TumorsCompletedNCT00303940Phase 1
- N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent NeuroblastomaCompletedNCT00295919Phase 1
- 131 I-MIBG in Treating Patients With Refractory or Relapsed NeuroblastomaCompletedNCT00293319Phase 2
- Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With NeuroblastomaStatus unknownNCT00287950Not applicable
- Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain TumorsStatus unknownNCT00281905Phase 2
- Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III NeuroblastomaStatus unknownNCT00276731Phase 3
- Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory NeuroblastomaCompletedNCT00276679Phase 2
- Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or LeukemiaCompletedNCT00217412Phase 1
- Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone InvolvementCompletedNCT00206388Phase 1
- Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide ChemotherapyCompletedNCT00187109Phase 1/2
- Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory NeuroblastomaCompletedNCT00186862Phase 1
- Therapy for Children With Advanced Stage High Risk NeuroblastomaCompletedNCT00186849Phase 2
- Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in RelapseStatus unknownNCT00180947Phase 2
- Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and SarcomasCompletedNCT00165139Phase 2
- Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and LymphomasCompletedNCT00152126Not applicable
- Therapy for Children With NeuroblastomaCompletedNCT00135135Phase 2
- ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid TumorsCompletedNCT00132158Phase 1
- Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or NeuroblastomaCompletedNCT00126412Phase 3
- Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous DiseaseCompletedNCT00118326Phase 1/2
- Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid TumorsCompletedNCT00112645Phase 1
- Campath-1H + FK506 and Methylprednisolone for GVHDCompletedNCT00109993Phase 2
- Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or NeuroblastomaStatus unknownNCT00101309Phase 1
- Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasCompletedNCT00101270Phase 1
- Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid TumorsCompletedNCT00093821Phase 1
- N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant NeuroblastomaCompletedNCT00093353Phase 1
- Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00091182Phase 2
- Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous TreatmentCompletedNCT00089258Phase 2
- Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal CancerTerminatedNCT00089245Phase 1
- Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma PatientsCompletedNCT00085930Phase 1
- Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant DiseasesStatus unknownNCT00084695Phase 2
- N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk NeuroblastomaCompletedNCT00084422Phase 1
- N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell TransplantationCompletedNCT00083135Phase 1
- Study of the Emotional Needs of Caregivers of Stem Cell Transplantation PatientsCompletedNCT00082654Not applicable
- Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationCompletedNCT00080873Not applicable
- Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid TumorsCompletedNCT00077454Phase 1
- Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or NeuroblastomaCompletedNCT00075634Phase 1
- Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or LymphomaStatus unknownNCT00072488Not applicable
- Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive NeuroblastomaCompletedNCT00070200Phase 1
- Voriconazole in Preventing Fungal Infections in Children With Neutropenia After ChemotherapyCompletedNCT00066599Phase 2
- Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell TransplantationCompletedNCT00064311Phase 1/2
- Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory NeuroblastomaCompletedNCT00062855Phase 1
- Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerCompletedNCT00060372Phase 1
- Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent NeuroblastomaTerminatedNCT00054405Phase 1
- Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk NeuroblastomaTerminatedNCT00053950Phase 1
- Fenretinide in Treating Children With Recurrent or Resistant NeuroblastomaCompletedNCT00053326Phase 2
- Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System CancerCompletedNCT00053118Phase 1
- Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid TumorsCompletedNCT00049023Phase 1
- Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After ChemotherapyCompletedNCT00048386Phase 1
- Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin LymphomaCompletedNCT00040911Not applicable
- Multiple Therapies in Treating Patients With Advanced NeuroblastomaCompletedNCT00040872Phase 2
- Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic NeuroblastomaCompletedNCT00037011Phase 1
- ABT-751 in Treating Young Patients With Refractory Solid TumorsCompletedNCT00036959Phase 1
- Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow TransplantationStatus unknownNCT00036712Phase 2
- Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With NeuroblastomaStatus unknownNCT00030719Phase 3
- Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of ChildhoodCompletedNCT00030667Phase 2
- Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to TherapyCompletedNCT00030108Phase 1
- R(+)XK469 in Treating Patients With Advanced NeuroblastomaCompletedNCT00028522Phase 1
- Eligibility Screening for a NCI Pediatric Oncology Branch Research StudyCompletedNCT00026780
- Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed NeuroblastomaCompletedNCT00025649Phase 2
- Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed NeuroblastomaCompletedNCT00025623Phase 2
- Combination Chemotherapy in Treating Infants With Newly Diagnosed NeuroblastomaCompletedNCT00025610Phase 2
- Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.CompletedNCT00025597Phase 2
- Combination Chemotherapy Before Surgery in Treating Children With Localized NeuroblastomaCompletedNCT00025428Phase 3
- Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic NeuroblastomaStatus unknownNCT00024193Phase 2
- Caspofungin Acetate in Treating Children With Fever and NeutropeniaCompletedNCT00020527Not applicable
- Temozolomide and O6-benzylguanine in Treating Children With Solid TumorsCompletedNCT00020150Phase 1
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed NeuroblastomaCompletedNCT00017368Phase 2
- Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With NeuroblastomaCompletedNCT00017225Phase 2
- CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II StudyStatus unknownNCT00013806Phase 2
- Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or LymphomasCompletedNCT00012181Phase 1
- Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or ColonCompletedNCT00010283Phase 1/2
- Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid TumorsCompletedNCT00007813Phase 1
- Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory NeuroblastomaCompletedNCT00006480Phase 1
- Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00006102Phase 2
- N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With NeuroblastomaCompletedNCT00005978Phase 1
- Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS TumorsCompletedNCT00005955Phase 2
- Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid TumorsCompletedNCT00005952Phase 1/2
- N99-02: Melphalan and Buthionine SulfoximineCompletedNCT00005835Phase 1
- Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With NeuroblastomaCompletedNCT00005576Phase 1
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With NeuroblastomaCompletedNCT00004188Phase 3
- Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid TumorsCompletedNCT00004157Phase 2
- Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With NeuroblastomaCompletedNCT00004110Phase 2
- Irinotecan in Treating Children With Refractory Solid TumorsCompletedNCT00004078Phase 2
- Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid TumorsTerminatedNCT00003926Phase 1
- Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationCompletedNCT00003887Phase 2
- Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal TumorsCompletedNCT00003846Phase 2
- Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other TumorsCompletedNCT00003750Phase 1